CK Life Sciences Int'l., (Holdings) Inc. (00775) reported that its authorized share capital remained at 15,000,000,000 ordinary shares, each with a par value of HKD 0.1, totaling HKD 1,500,000,000 at the end of January 2026. The number of issued shares stood at 9,611,072,400 with no treasury shares, reflecting no changes from the previous month.
The company confirmed that it satisfied the applicable public float requirement of 25% of its total issued shares as of January 31, 2026, and no movements were recorded for share options, warrants, or any other convertible instruments during the period under review.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.